{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470477572
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = [[CD19]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 235428-87-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Taplitumomab paptox''' is a [[mouse]] [[monoclonal antibody]] designed for the treatment of cancer.{{Citation needed|date=October 2009}} The antibody itself, taplitumomab, is linked to the protein PAP, an antiviral from ''[[Phytolacca americana]]'', a species of [[pokeweed]].<ref>[http://whqlibdoc.who.int/druginfo/INN_2001_list46.pdf WHO Drug Information]</ref> This is reflected by the 'paptox' in the drug's name.

==References==
{{reflist}}

{{Monoclonals for tumors}}

{{DEFAULTSORT:Taplitumomab Paptox}}
[[Category:Monoclonal antibodies for tumors]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}